FDA-Cleared • AI-Enabled • Physician Prescribed
Parkinson's Management on Apple Watch
About
NeuroRPM-Rx
for You
Empower your Parkinson’s management with NeuroRPM-Rx. Harnessing advanced AI, NeuroRPM-Rx on Apple Watch monitors three cardinal symptoms of Parkinson's — bradykinesia, tremor, and dyskinesia — along with comprehensive medication management, and health information from Apple’s Healthkit.
-
Analytics & Assessment Tools: AI-powered, real-time detection and visualization of bradykinesia, tremors, and dyskinesias from your Apple Watch, offering an instantaneous insight into your Parkinson’s symptoms on your iPhone.
-
Medication Tracking & Insights: Manage your medication schedule effortlessly.
-
HealthKit Integration: With seamless integration into HealthKit, NeuroRPM-Rx amplifies your wellness monitoring, providing a holistic view of your health.
About
NeuroRPM-CT
for Drug Trials
Elevate your clinical trials with NeuroRPM-CT. Tailored for pharmaceutical and medical device research, our tools objectively monitor Parkinson's key symptoms - tremor, bradykinesia, dyskinesia - and integrate supplemental data from Apple Healthkit. Our precise symptom classification and treatment efficacy metrics offer unparalleled granularity in clinical trial data tracking. Complementing traditional reporting, NeuroRPM-CT delivers clear, data-driven insights, adaptable to any stage of your trial needs.
If you are interested in using NeuroRPM-CT for your clinical trial or for R&D in your therapy development, please contact us so we answer any questions you may have.
About Us
NeuroRPM, headquartered in Washington, D.C., is a digital health company focused on improving care for people living with neurodegenerative disease. NeuroRPM developed the first FDA-cleared AI-enabled medical device for continuous monitoring of Parkinson’s disease symptoms, combining Apple Watch, mobile software, and data analytics to bring objective symptom insights into everyday care.
Our mission is to help transform the care model for Parkinson’s disease and, over time, other neurodegenerative conditions. By integrating the NeuroRPM platform into the daily workflows of physicians, patients, and industry partners, we support more informed treatment decisions, stronger patient engagement, and a clearer view of symptom patterns in real-world settings. Today, NeuroRPM is available by physician prescription and is also being used in clinical research and trial collaborations.
On March 17, 2023, NeuroRPM received FDA clearance for monitoring Parkinson’s disease symptoms on Apple Watch. You can read the press release to learn more.
You may also register to learn more about our technology and receive updates.